Neurontin is owned by Viatris.
Neurontin contains Gabapentin.
Neurontin has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Neurontin are:
Neurontin was authorised for market use on 02 March, 2000.
Neurontin is available in solution;oral dosage forms.
The generics of Neurontin are possible to be released after 28 November, 2022.
|Patent Number||Company||Patent Title||Patent Expiry||Activity Alert|
|These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).|
|US7256216||VIATRIS||Liquid pharmaceutical compositions|| |
(8 months ago)
|VIATRIS||Liquid pharmaceutical compositions|| |
(2 months ago)
Market Authorisation Date: 02 March, 2000
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic